Neurocognitive Disorders

How I Treat My Patients With Sacubitril/Valsartan for Heart Failure With Reduced Ejection Fraction

Congestive heart failure (CHF) remains a leading cause of death and expenditure in the United States, affecting approximately 6.5 million people and costing more than $30 billion annually.1,2 Despite advances in medical therapy, the 5-year survival for patients with CHF is still approximately 50%.3 The prevalence of heart failure in the United States is expected…

Next post in CHD